{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:02:00Z","timestamp":1788912120110,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.jns.2007.01.028","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T12:46:45Z","timestamp":1172839605000},"page":"31-37","source":"Crossref","is-referenced-by-count":50,"title":["Homocysteine and Parkinson's disease: A dangerous liaison?"],"prefix":"10.1016","volume":"257","author":[{"given":"E.","family":"Martignoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zangaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Blandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2007.01.028_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.advenzreg.2003.11.012","article-title":"Methylation demand and homocysteine metabolism.","volume":"44","author":"Stead","year":"2004","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.jns.2007.01.028_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2007.01.028_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jns.2007.01.028_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jcp.1041460108","article-title":"Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture","volume":"146","author":"Christensen","year":"1991","journal-title":"J Cell Physiol"},{"issue":"Pt 2","key":"10.1016\/j.jns.2007.01.028_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/bj2980415","article-title":"Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism","volume":"298","author":"Miller","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.jns.2007.01.028_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s002340050119","article-title":"Hyperhomocysteinaemia; with reference to its neuroradiological aspects","volume":"37","author":"van den","year":"1995","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jns.2007.01.028_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ajmg.1320340320","article-title":"Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity","volume":"3","author":"Watkins","year":"1989","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jns.2007.01.028_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1018675624181","article-title":"Homocysteine and risk of cardiovascular disease","volume":"9","author":"Andreotti","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jns.2007.01.028_bib9","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S0140-6736(05)65956-9","article-title":"Serum total homocysteine concentration and risk of stroke","volume":"348","author":"Perry","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2007.01.028_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1345\/aph.18457","article-title":"Homocysteine as a risk factor for atherosclerosis","volume":"34","author":"Temple","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jns.2007.01.028_bib11","doi-asserted-by":"crossref","first-page":"341S","DOI":"10.1042\/bst022341s","article-title":"Homocysteine induced endothelial cell toxicity and its protection","volume":"22","author":"Blundell","year":"1994","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jns.2007.01.028_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(95)05730-7","article-title":"Homocysteine mediated endothelial cell toxicity and its amelioration","volume":"122","author":"Blundell","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2007.01.028_bib13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00007890-200202270-00034","article-title":"Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients","volume":"73","author":"Abdelfatah","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jns.2007.01.028_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI118776","article-title":"The oxidant stress of hyperhomocyst(e)inemia","volume":"98","author":"Loscalzo","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2007.01.028_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.1175","article-title":"Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function","volume":"82","author":"Mujumdar","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jns.2007.01.028_bib16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.HYP.0000127914.94292.76","article-title":"Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways","volume":"43","author":"Suhara","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jns.2007.01.028_bib17","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1096\/fj.00-0848com","article-title":"Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity","volume":"15","author":"Bessede","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2007.01.028_bib18","doi-asserted-by":"crossref","first-page":"35867","DOI":"10.1074\/jbc.M100747200","article-title":"Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2007.01.028_bib19","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2007.01.028_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0167-5699(94)90018-3","article-title":"Oxidative stress as a mediator of apoptosis","volume":"15","author":"Buttke","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.jns.2007.01.028_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/10715760400017269","article-title":"No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans","volume":"38","author":"Huerta","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jns.2007.01.028_bib22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/j.1432-1033.2004.04070.x","article-title":"Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes","volume":"271","author":"Mangiagalli","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jns.2007.01.028_bib23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jn\/128.7.1204","article-title":"Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women","volume":"128","author":"Jacob","year":"1998","journal-title":"J Nutr"},{"key":"10.1016\/j.jns.2007.01.028_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/07315724.1998.10718790","article-title":"Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis","volume":"17","author":"Siri","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jns.2007.01.028_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2007.01.028_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/ars.2005.7.813","article-title":"The role of cystathionine beta-synthase in homocysteine metabolism","volume":"7","author":"Jhee","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jns.2007.01.028_bib27","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1161\/01.CIR.94.12.3074","article-title":"Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease","volume":"94","author":"Deloughery","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2007.01.028_bib28","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/01.CIR.94.10.2410","article-title":"Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians","volume":"94","author":"Ma","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2007.01.028_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2003.1.62","article-title":"Update on cobalamin, folate, and homocysteine","author":"Carmel","year":"2003","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.jns.2007.01.028_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.pnpbp.2005.06.025","article-title":"The central nervous system in animal models of hyperhomocysteinemia","volume":"29","author":"Troen","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jns.2007.01.028_bib31","first-page":"1894","article-title":"Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate\/methyl-deficient rats","volume":"55","author":"Pogribny","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jns.2007.01.028_bib32","first-page":"2071s","article-title":"Methyl groups in carcinogenesis: effects on DNA methylation and gene expression","volume":"52","author":"Wainfan","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.jns.2007.01.028_bib33","first-page":"471","article-title":"Hyperhomocysteinemia: a new risk factor for degenerative diseases","volume":"48","author":"Herrmann","year":"2002","journal-title":"Clin Lab"},{"key":"10.1016\/j.jns.2007.01.028_bib34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/znc-1995-9-1017","article-title":"Homocysteine-induced oxidative damage: mechanisms and possible roles in neurodegenerative and atherogenic processes","volume":"50","author":"Schlussel","year":"1995","journal-title":"Z Naturforsch [C]"},{"key":"10.1016\/j.jns.2007.01.028_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0163-7258(96)00097-6","article-title":"The neurotransmitter candidature of sulphur-containing excitatory amino acids in the mammalian central nervous system","volume":"72","author":"Thompson","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jns.2007.01.028_bib36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","article-title":"Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage","volume":"70","author":"Ho","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2007.01.028_bib37","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1523\/JNEUROSCI.22-05-01752.2002","article-title":"Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease","volume":"22","author":"Kruman","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2007.01.028_bib38","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","article-title":"Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor","volume":"94","author":"Lipton","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2007.01.028_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease","volume":"80","author":"Duan","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2007.01.028_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00969090","article-title":"The effects of l-dopa on the activity of methionine adenosyltransferase: relevance to l-dopa therapy and tolerance","volume":"18","author":"Benson","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2007.01.028_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002826-199702000-00007","article-title":"Effect of l-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats","volume":"20","author":"Miller","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jns.2007.01.028_bib42","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0024-3205(00)00557-9","article-title":"Effects of l-dopa treatment on methylation in mouse brain: implications for the side effects of l-dopa","volume":"66","author":"Liu","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jns.2007.01.028_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002826-199702000-00007","article-title":"Effect of l-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats","volume":"20","author":"Miller","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jns.2007.01.028_bib44","first-page":"527","article-title":"Sulfate and cysteine levels in the plasma of patients with Parkinson's disease","volume":"16","author":"Allain","year":"1995","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jns.2007.01.028_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","article-title":"Elevated plasma levels of homocysteine in Parkinson's disease","volume":"40","author":"Kuhn","year":"1998","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2007.01.028_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease","volume":"60","author":"Rogers","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2007.01.028_bib47","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/mds.20253","article-title":"Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease","volume":"19","author":"O'suilleabhain","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2007.01.028_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations","volume":"61","author":"O'suilleabhain","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2007.01.028_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-1331.2004.00973.x","article-title":"Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration","volume":"12","author":"Lamberti","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2007.01.028_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.parkreldis.2004.07.008","article-title":"Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications","volume":"11","author":"Zoccolella","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2007.01.028_bib51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/clinchem\/47.6.1102","article-title":"Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease","volume":"47","author":"Blandini","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jns.2007.01.028_bib52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(99)01660-8","article-title":"Nigral endothelial dysfunction, homocysteine, and Parkinson's disease","volume":"354","author":"Muller","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2007.01.028_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01972-3","article-title":"Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease","volume":"308","author":"Muller","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2007.01.028_bib54","doi-asserted-by":"crossref","first-page":"F786","DOI":"10.1152\/ajprenal.00465.2004","article-title":"Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers.","volume":"289","author":"Fux","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jns.2007.01.028_bib55","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4088\/JCP.v66n1210","article-title":"High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and\/or tardive dyskinesia","volume":"66","author":"Lerner","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jns.2007.01.028_bib56","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1176\/appi.ajp.161.9.1705","article-title":"Folate, homocysteine, and negative symptoms in schizophrenia","volume":"161","author":"Goff","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jns.2007.01.028_bib57","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1176\/appi.ajp.162.7.1387-a","article-title":"The significance of homocysteine levels in schizophrenia","volume":"162","author":"O\u2019Donnell","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jns.2007.01.028_bib58","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1176\/appi.ajp.162.7.1388","article-title":"Letter to the editor","volume":"162","author":"Goff","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jns.2007.01.028_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.20509","article-title":"Methylenetetrahydrofolate reductase C677T genotype and PD","volume":"57","author":"de Lau","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.01.028_bib60","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00702-002-0758-8","article-title":"Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2007.01.028_bib61","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.amjmed.2005.01.052","article-title":"Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease","volume":"118","author":"Sato","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jns.2007.01.028_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0009-8981(73)90429-4","article-title":"The reaction of homocysteine with aldehyde: an explanation of the collagen defects in homocystinuria","volume":"45","author":"Jackson","year":"1973","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jns.2007.01.028_bib63","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000183063.99107.5c","article-title":"Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease","volume":"65","author":"Irizarry","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2007.01.028_bib64","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1074\/jbc.M112372200","article-title":"Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein","volume":"277","author":"Sai","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2007.01.028_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(03)00277-1","article-title":"Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease?","volume":"541","author":"Scarpa","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jns.2007.01.028_bib66","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcn\/82.3.627","article-title":"High homocysteine and low B vitamins predict cognitive decline in aging men; the Veterans Affairs Normative Aging Study","volume":"82","author":"Tucker","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jns.2007.01.028_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjmed.2004.08.019","article-title":"Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging","volume":"118","author":"Kado","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jns.2007.01.028_bib68","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/ajcn\/82.4.866","article-title":"Homocysteine, vitamin B12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study","volume":"82","author":"Mooijaart","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jns.2007.01.028_bib69","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/mds.20667","article-title":"Homocysteine and serum markers if immune activation in primary dystonia","volume":"20","author":"Muller","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2007.01.028_bib70","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1254\/jphs.CRJ05003X","article-title":"The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins","volume":"98","author":"Hamed","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jns.2007.01.028_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2005.11.002","article-title":"Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6","volume":"15","author":"Sener","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2007.01.028_bib72","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/ajcn\/82.6.1320","article-title":"Westendorp Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease","volume":"82","author":"Stott","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jns.2007.01.028_bib73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.archger.2005.10.002","article-title":"Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects","volume":"43","author":"Pathansali","year":"2006","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jns.2007.01.028_bib74","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/01.WNL.0000158476.74580.A8","article-title":"Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment","volume":"64","author":"Boxer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2007.01.028_bib75","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.WNL.0000137886.74175.5A","article-title":"Homocysteine and l-Dopa: should Parkinson disease patients receive preventive therapy?","volume":"63","author":"Postuma","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2007.01.028_bib76","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/aje\/kwh213","article-title":"Folate intake and risk of Parkinson's disease","volume":"160","author":"Chen","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jns.2007.01.028_bib77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-277X.2004.00532.x","article-title":"A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly","volume":"17","author":"Ellinson","year":"2004","journal-title":"J Hum Nutr Diet"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T05:10:54Z","timestamp":1587359454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X07000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":77,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0022510X07000548"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2007.01.028","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}